NCT03011710

Brief Summary

Electronic cigarettes are battery-powered vaporizers which have a similar feel to tobacco smoking. They do not produce cigarette smoke but rather an aerosol, which is frequently referred to as vapor. E-cigarettes are marketed as less harmful alternatives to smoking. Use and awareness of these devices has grown exponentially in recent years, with millions of people currently using them. The benefits and risks of electronic cigarette use are uncertain. There is no research on the acute oral effects of electronic cigarette in the scientific literature and no hungarian epidemiological survey has been performed in this topic. Regulation of electronic cigarettes varies across countries in the European Union, ranging from no regulation to banning them entirely. The investigators research could help to integrate the regulation of this device in Hungary and in the EU as well. The measurement of acute oral effects of e-cigarette and a hungarian epidemiological survey would be novel in this topic.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2017

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 22, 2023

Completed
Last Updated

November 29, 2023

Status Verified

July 1, 2022

Enrollment Period

8.2 years

First QC Date

January 4, 2017

Last Update Submit

November 23, 2023

Conditions

Keywords

e-cigaretteblood floworal effectsoral pH

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in blood flow after vaping/smoking

    The blood flow changes are measured by Laser Speckle Contrast Analyzer (LASCA) before (baseline) and after vaping/smoking.

    baseline, immediately after smoking/vaping, and 15 minutes after smoking/vaping

Study Arms (4)

E-cigarette with nicotine

EXPERIMENTAL

Nicotine level: 6 mg/ml

Device: ProVari v2.5 (E-cigarette)

E-cigarette without nicotine

EXPERIMENTAL

Nicotine level: 0 mg/ml

Device: ProVari v2.5 (E-cigarette)

Conventional cigarette

EXPERIMENTAL

Nicotine content: 0,5mg

Device: Marlboro Gold (Conventional cigarette)

Cigarette tip

PLACEBO COMPARATOR

Placebo device

Device: Cigarette tip

Interventions

An electronic cigarette or e-cigarette is a handheld electronic device that vaporizes a flavored liquid. The user inhales the vapor. The fluid in the e-cigarette, called e-liquid, is usually made of nicotine, propylene glycol, glycerine, and flavorings.

Also known as: ProVari v2.5
E-cigarette with nicotineE-cigarette without nicotine

Conventional cigarette

Also known as: Marlboro Gold 0,6mg
Conventional cigarette

Placebo device

Cigarette tip

Eligibility Criteria

Age19 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age: 19-49 years
  • signed consent form
  • smoking regularly e-cigarette and/or conventional cigarette for \> half year

You may not qualify if:

  • not pregnant and not planning pregnancy in the next 6 month
  • BMI index \< 30
  • no severe parodontal disease
  • no acute illness in the last 2 weeks
  • no chronic disease (eg.: diabetes)
  • no diet which can influence the oral pH

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tobacco Use DisorderVaping

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersSmokingBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2017

First Posted

January 5, 2017

Study Start

September 1, 2015

Primary Completion

November 22, 2023

Study Completion

November 22, 2023

Last Updated

November 29, 2023

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share